3.
DISCONTINUED OPERATIONS During the second quarter of 2012, the Board of Directors authorized the sale of our Homecare business, which had previously been reported as part of the Merchant Gases operating segment.
This business has been accounted for as a discontinued operation.
In the third quarter of 2012, we sold the majority of our Homecare business to The Linde Group for sale proceeds of 3.
DISCONTINUED OPERATIONS During the second quarter of 2012, the Board of Directors authorized the sale of our Homecare business, which had previously been reported as part of the Merchant Gases operating segment.
This business has been accounted for as a discontinued operation.
In the third quarter of 2012, we sold the majority of our Homecare business to The Linde Group for sale proceeds of €590 million ($777) and recognized a gain of $207.4 ($150.3 after-tax, or $.70 per share).
The sale proceeds included €110 million ($144) that was contingent on the outcome of certain retender arrangements.
These proceeds were reflected in payables and accrued liabilities on our consolidated balance sheet as of 30 September 2013.
Based on the outcome of the retenders, we were contractually required to return proceeds to The Linde Group.
In the fourth quarter of 2014, we made a payment to settle this liability and recognized a gain of $1.5.
During the third quarter of 2012, an impairment charge of $33.5 ($29.5 after-tax, or $.14 per share) was recorded to write down the remaining business, which was primarily in the United Kingdom and Ireland, to its estimated net realizable value.
In the fourth quarter of 2013, an additional charge of $18.7 ($13.6 after-tax, or $.06 per share) was recorded to update our estimate of the net realizable value.
In the first quarter of 2014, we sold the remaining portion of the Homecare business for ¡ê6.1 million ($9.8) and recorded a gain on sale of $2.4.
We entered into an operations guarantee related to the obligations under certain homecare contracts assigned in connection with the transaction.
Refer to Note 16, Commitments and Contingencies, for additional information.
The results of discontinued operations are summarized below:
## Table 0 ##
The assets and liabilities classified as discontinued operations for the Homecare business at 30 September 2013 consisted of $2.5 in trade receivables, net, and $2.4 in payables and accrued liabilities.
As of 30 September 2014, no assets or liabilities were classified as discontinued operations.
D. R.  HORTON, INC.  AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued) The Company measures and recognizes compensation expense at an amount equal to the fair value of share-based payments granted under compensation arrangements.
The weighted average fair value of options granted in fiscal 2014 and 2013 was $11.21 per share and $10.92 per share, respectively.
The fair values of the options granted were estimated on the date of their grant using the Black-Scholes option pricing model based on the following weighted average assumptions:
## Table 1 ##
For fiscal 2014, 2013 and 2012, the Company’s compensation expense related to stock option grants was $25.5 million, $18.6 million and $15.1 million, respectively, and at September 30, 2014, there was $71.7 million of total unrecognized compensation expense related to unvested stock option awards.
This expense is expected to be recognized over a weighted average period of 3.75 years.
Incentive Bonus Plan The Company's Incentive Bonus Plan provides for the Compensation Committee to award short-term performance bonuses to senior management based upon the level of achievement of certain criteria.
For fiscal 2014, 2013 and 2012 the Compensation Committee approved awards whereby certain executive officers could earn performance bonuses based upon percentages of the Company's pre-tax income.
Compensation expense related to these plans was $11.8 million, $9.8 million and $4.9 million in fiscal 2014, 2013 and 2012, respectively.
Restricted Stock Unit Agreement The Company has a Restricted Stock Unit Agreement (RSU Agreement) for awards to certain executive officers, other key employees and non-management directors pursuant to the Stock Incentive Plan.
Under the RSU Agreement, the Compensation Committee may award performance or service (time) based restricted stock units subject to the terms and conditions of the RSU Agreement and the Stock Incentive Plan.
In September 2010, the Compensation Committee approved and granted awards of 200,000 performance based restricted stock units (Performance RSUs) that vested at the end of a two-year performance period that ended September 30, 2012.
The number of units that vested depended on the Company's relative position as compared to its peers at the end of the two-year period in achieving certain performance criteria and ranged from 0% to 200% of the number of units granted.
The performance criteria were total shareholder return, return on investment, SG&A expense containment and gross profit.
Each Performance RSU represented the contingent right to receive one share of the Company's common stock if the vesting conditions were satisfied.
The Performance RSUs had no dividend or voting rights during the performance period.
The fair value of these awards on the date of grant was $11.53 per unit.
Based on the achievement of the performance criteria, 325,000 Performance RSUs were earned and vested on September 30, 2012.
Compensation expense for these awards was based on the Company's performance against the peer group, the elapsed portion of the performance period and the grant date fair value of the award.
Compensation expense for these awards was $2.6 million in fiscal 2012.
ITEM 6.
SELECTED FINANCIAL DATA The following selected consolidated financial data are derived from our Consolidated Financial Statements.
The data should be read in conjunction with Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” Item 1A, “Risk Factors,” Item 8, “Financial Statements and Supplementary Data,” and all other financial data contained in this annual report on Form 10-K.
These historical results are not necessarily indicative of the results to be expected in the future.
## Table 2 ##
September 30,
## Table 3 ##
(1) The income tax benefit in fiscal 2012 reflects a $753.2 million reduction of our deferred tax asset valuation allowance during the year.
The income tax benefit in fiscal 2011 was due to receiving a favorable result from the Internal Revenue Service on a ruling request concerning capitalization of inventory costs, and the income tax benefit in fiscal 2010 resulted from a tax law change regarding net operating loss (NOL) carrybacks.
(2) At September 30, 2013 we recorded an out-of-period adjustment which increased both our deferred income taxes and the valuation allowance on our deferred income taxes by $23.9 million.
The out-of-period adjustment had no impact on our statement of operations during fiscal 2013.
Had deferred income taxes related to the state NOL carryforwards of each of our legal entities been reflected at state specific tax rates as of September 30, 2012, our deferred income taxes would have increased by $31.6 million and the corresponding valuation allowance on our deferred income taxes would have increased by $37.6 million.
This would have resulted in a decrease in our income tax benefit of $6.0 million in fiscal 2012, which would have reversed and decreased our income tax expense by $6.0 million in fiscal 2013.
The unadjusted amounts from fiscal 2012 were not material to our financial statements for fiscal 2012, and the out-of-period adjustment recorded in fiscal 2013 was not material to our financial statements for fiscal 2013.
(3) Cash balances of our captive insurance subsidiary, which are expected to be used to pay future anticipated legal claims, have been correctly presented within cash and cash equivalents rather than other assets as classified in prior years.
These balances were $40.9 million, $39.1 million, $37.9 million and $38.0 million at September 30, 2013, 2012, 2011 and 2010, respectively.
(4) Notes payable includes both homebuilding notes payable and the amount outstanding on our mortgage repurchase facility

['

2014	2013	2012
Sales	$8.5	$52.3	$258.0
Income before taxes	$.7	$3.8	$68.1
Income tax provision	—	.2	20.8
Income from operations of discontinued operations	.7	3.6	47.3
Gain (Loss) on sale of business and impairment/write-down, net of tax	3.9	-13.6	120.8
Income (Loss) from Discontinued Operations, net of tax	$4.6	$-10.0	$168.1

', '

Year Ended September 30,
2014	2013	2012
Risk free interest rate	2.01%	1.13%	—
Expected life (in years)	6.48	6.46	—
Expected volatility	48.80%	49.30%	—
Expected dividend yield	0.63%	0.63%	—

', '

Year Ended September 30,
2014	2013	2012	2011	2010
(In millions, except per share data)
Operating Data:
Revenues:
Homebuilding	$7,858.5	$6,085.9	$4,236.2	$3,549.6	$4,309.7
Financial Services	166.4	173.4	117.8	87.2	90.5
Inventory and land option charges	85.2	31.1	6.2	45.4	64.7
Gross profit — Homebuilding	1,589.9	1,232.4	743.8	526.3	682.1
Income (loss) before income taxes:
Homebuilding	768.8	592.3	203.7	-7.0	78.1
Financial Services	45.4	65.5	39.2	19.1	21.4
Income tax expense (benefit) (1) (2)	280.7	195.1	-713.4	-59.7	-145.6
Net income	533.5	462.7	956.3	71.8	245.1
Net income per share:
Basic	1.57	1.44	3.01	0.23	0.77
Diluted	1.50	1.33	2.77	0.23	0.77
Cash dividends declared per common share	0.1375	0.1875	0.15	0.15	0.15

', '

September 30,
2014	2013	2012	2011	2010
(In millions)
Balance Sheet Data:
Cash and cash equivalents and marketable securities -3	$661.8	$977.4	$1,384.8	$1,068.1	$1,645.0
Inventories	7,700.5	6,197.4	4,165.2	3,449.7	3,449.0
Total assets	10,202.5	8,856.4	7,248.2	5,358.4	5,938.6
Notes payable -4	3,682.8	3,509.0	2,493.1	1,704.6	2,171.8
Total equity	5,119.7	4,061.4	3,594.7	2,623.5	2,622.9

']

Question: What is the sum of Cash and cash equivalents and marketable securities, Inventories and Total assets in 2014? (in million)
Answer: 18564.8